2 Reperfusion of cultured astrocytes with normal medium after exposure to hydrogen peroxide (H 2 O 2 )-containing medium causes apoptosis. We have recently shown that ibudilast, which has been used for bronchial asthma and cerebrovascular disorders, attenuated the H 2 O 2 -induced apoptosis of astrocytes via cGMP signaling pathway. This study examined the mechanism underlying the protective effect of cGMP. The membrane-permeable cGMP analog dibutyryl-cGMP attenuated the H 2 O 2 -induced decrease in cell viability, DNA ladder formation, nuclear condensation, reduction of the mitochondrial membrane potential, cytochrome c release from mitochondria and caspase-3 activation in a dose-dependent manner in cultured astrocytes. These effects of dibutyryl-cGMP were almost completely inhibited by the cGMP-dependent protein kinase (PKG) inhibitor KT5823. In isolated rat brain mitochondria, cGMP in the presence of cytosolic extract from astrocytes inhibited the mitochondrial permeability transition pore (PTP) as determined by monitoring Ca 2+ -induced mitochondrial swelling. This ability of the cytosolic extract was inactivated by heat treatment and was mimicked by exogenous PKG. The effect of cGMP on the mitochondrial swelling was blocked by KT5823. The PTP inhibitors cyclosporin A and bongkrekic acid prevented the H 2 O 2 -induced decrease in cell viability and caspase-3 activation. These findings demonstrate that cGMP inhibits the mitochondrial PTP via the activation of PKG, and the prevention of mitochondrial dysfunction contributes to its anti-apoptotic effect.
We previously showed that reperfusion of cultured rat astrocytes with Ca 2+ -containing medium after exposure to Ca 2+ -free medium caused an increase in intracellular Ca 2+ concentration followed by delayed cell death, including apoptosis (1) (2) (3) . This injury is considered to be an in vitro model of ischemia/reperfusion injury, because a similar paradoxical change in extracellular Ca 2+ concentration is reported in ischemic brain tissue (4) (5) (6) . Subsequently, we have found that the Ca 2+ reperfusion injury was mimicked by reperfusion after exposure to hydrogen peroxide (H 2 O 2 ) (3). Our previous studies using the astrocytic injury models show that heat shock protein (7), calcineurin (8) , mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (9) , phosphatidylinositol-3 kinase (9,10) and cGMP phosphodiesterase (11) are target molecules for anti-apoptotic drugs in astrocytic apoptosis. The role of cGMP in preventing apoptosis is also reported in B lymphocytes (12) , T lymphocytes (13) , eosinophils (14) , motor and sympathetic neurons (15, 16) , hepatocytes (17, 18) , PC12 cells (15, 19) , and ovarian follicles (20) . However, it is not known how cGMP prevents apoptosis signaling and supports survival.
It is considered that the mitochondrial permeability transition pore (PTP) and associated release of cytochrome c are important in the apoptotic process. Kim et al. (19) and Li et al. (18) have recently reported that cGMP inhibits caspase activation and cytochrome c release.
We (11) found that ibudilast, which has been clinically used for bronchial asthma and cerebrovascular disorders, inhibited the H 2 O 2 -induced cytochrome c release and caspase-3 activation in a cGMP-dependent mechanism. It is not known whether cGMP acts on the mitochondrial PTP. In this study, we examined the effects of cGMP on mitochondrial dysfunction resulting in astrocytic apoptosis and on mitochondrial PTP in isolated brain mitochondria. The present study demonstrates that dibutyryl-cGMP prevents the H 2 O 2 -induced reduction of the mitochondrial membrane potential, cytochrome c release and caspase by guest on January 8, 2018 http://www.jbc.org/ Downloaded from activation. In addition, we demonstrate in isolated rat brain mitochondria that cGMP inhibits the mitochondrial PTP in a PKG-mediated mechanism as determined by monitoring Ca 2+ -induced mitochondrial swelling. 
MATERIALS AND METHODS

Materials-Drugs
Peptide Institute, Inc. (Osaka, Japan); anti-cytochrome c antibody (clone 7H8.2C12), Pharmingen (San Diego, CA); wortmannin, Nacalai Tesque (Kyoto, Japan); Eagle's minimum essential medium, Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan), tissue culture wares, Iwaki Glass Co., Ltd. (Tokyo, Japan). All other chemicals used were of the highest purity commercially available.
Astrocyte culture-Astrocytes were isolated from the cerebral cortices of 1-day-old Wistar rats as previously reported (21) (22) (23) . Cells were plated in 75-ml tissue culture flasks, split once upon confluence, and plated in 24-well (for MTT assay) and 96-well (for mitochondria energization and caspase assays) plastic tissue culture plates, 60-mm (for DNA ladder) and 100-mm (for cytochrome c release analysis and cell extract preparation) plastic tissue culture dishes, and 4-well chamber slides (for fluorescence microscopy). The second cultures were grown for 14-20 days in all experiments. The cells were routinely >95% positive for glial fibrillary acidic protein, and approximately 2% of the cells showed microglia, based on positive isolectin B 4 staining.
Cell viability-Reperfusion experiments were carried out as previously reported (9,10). Cells were exposed to H 2 O 2 (100 µM)-containing Earle's solution for 30 min, and then incubated with normal Earle's solution for the indicated times. MTT reduction activity was measured by a colorimetric assay as reported previously (1, 3) . MTT reduction activity is expressed as a percentage of control.
DNA ladder and Hoechst 33342 staining-DNA was extracted and subjected to 1.8% agarose gel electrophoresis as previously reported (9, 10) . DNA in the gel was stained with ethidium bromide and photographed with a Polaroid (type 667) under UV light. To observe individual nuclei, the cells plated on a chamber slide were fixed with 4% formaldehyde and stained with Hoechst 33342 as previously reported (3, 10) . An Olympus IX70 inverted fluorescencemicroscope was equipped with a cooled CCD camera system (Roper Scientific, Photometrics CoolSNAP) to scan the staining nuclear images.
Measurement of Mitochondrial Energization-Mitochondria energization was determined as the retention of the mitochondria-specific dye DiOC 6 (3) (24). Cells were loaded with 100 nM DiOC 6 (3) during the last 30 min of treatment. After removing the medium, the cells were washed twice with PBS and then lysed by the addition of 100 µl of deionized water. The concentration of retained DiOC 6 (3) was measured with excitation at 485 nm and emission at 510 nm using a Wallac Multilabel counter.
Measurement of cytochrome c release-Cytosol and membrane fractions were prepared as previously reported (11) . The protein contents of the cytosol and membrane fractions were determined by a BioRad DC protein assay (BioRad Laboratories, Hercules, CA), and 15 µg of the sample was subjected to SDS-polyacrylamide gel electrophoresis (15% polyacrylamide). A cytochrome c antibody (1:1000) was used for immunoblotting.
Measurement of caspase activity-The activity of caspase-3-like protease in cell lysates was measured using the fluogenic substrate Ac-DEVD-MCA (11) . After reacting for 1 h at 37°C, the released 7-amino-4-methyl-coumarin levels were measured with excitation at 355 nm and emission at 460 nm using a Wallac Multilabel counter.
Cytosolic extract from astrocytes-The cytosol extracts were prepared as follows. Cells plated on 100 mm dishes were washed twice with cold phosphate-buffered saline, scraped off using a policeman, and collected by centrifugation at 300 g for 10 min at 4°C. The pellet was suspended in 100 µl of lysis buffer (320 mM sucrose, 10 mM Tris-base, pH 7.4), and disrupted with 10 strokes of a Daunce homogenizer. The homogenate was centrifuged at 105,000 g for 1 h at 4°C, and the resulting supernatant (approximately 10 mg protein/ml) was kept at -80°C.
Measurement of the MPT pore opening by swelling in isolated mitochondria-Brain mitochondria were isolated from male Wistar rats (120-140 g) by the method of Sims (25) using a discontinuous Percoll gradient centrifugation. The mitochondrial fraction was resuspended in buffer containing sucrose (320 mM) and Tris-base (10 mM, pH 7.4) and kept on ice until use. Opening of the PTP causes mitochondrial swelling that is conveniently assayed as a decrease in the light scattering (and thus absorbance) of a mitochondrial suspension. The Ca 2+ -induced mitochondrial swelling was assayed essentially as described by Friberg et al. (26) . Rotenone, antimycin and A23187 were added 5 min before the addition of CaCl 2 solution to ensure complete equilibration of calcium ions across the mitochondrial membrane under de-energized conditions. The treatment of mitochondrial suspension (0.5 mg/ml) with cGMP, the cytosolic extract or PKG was carried out for 15 min before the addition of CaCl 2 solution. The calcium ion concentrations were calculated from the NTA buffering (27) . Absorbance at 540 nm was measured using a Shimadzu UV1200 spectrophotometer (Kyoto, Japan). Each experiment shown is representative of at least three similar experiments performed on separate mitochondrial preparations. Statistics-Statistical analysis of the experimental data was carried out by Student-NewmanKeuls test, Dunnett's t test or Tukey HSD test, using a software package (Stat View 5.0) for Apple Macintosh.
RESULTS
Reperfusion after exposure of astrocytes to H 2 O 2 -containing medium causes a decrease in MTT reduction activity, DNA ladder formation, cytochrome c release from mitochondria and caspase-3 like protease activation (3). Fig. 1 shows the effects of membrane-permeable cGMP analogs on the H 2 O 2 -induced apoptosis. Dibutyryl-cGMP, 8-pCPT-cGMP and Sp-8-pCPT-cGMPS attenuated significantly the H 2 O 2 -induced decrease in MTT reduction activity in a dose-dependent manner: the effect of Sp-8-pCPT-cGMPS was more potent than those of dibutyryl-cGMP and 8-pCPT-cGMP. The protective effect of dibutyryl-cGMP was observed even in the presence of the ERK kinase inhibitor PD98059 and the phosphoinositide-3 kinase inhibitor wortmannin (data not shown). Dibutyryl-cGMP also attenuated the H 2 O 2 -induced DNA ladder formation ( Fig. 2A ) and nuclear condensation (Fig. 2B) . Reperfusion after the exposure of astrocytes to H 2 O 2 also caused a decrease in DiOC 6 (3) retention, which reflects mitochondrial membrane potential (Fig. 3A) . The H 2 O 2 -induced loss of mitochondrial membrane potential was inhibited by dibutyryl-cGMP in a dose-dependent manner (Fig. 3B) . Furthermore, dibutyryl-cGMP attenuated the H 2 O 2 -induced cytochrome c release from mitochondria and caspase-3-like protease activation in a dose-dependent manner (Fig. 4) .
The protection by dibutyryl-cGMP against the H 2 O 2 -induced decrease in MTT reduction activity was blocked by the PKG inhibitors KT5823 and Rp-8-pCPT-cGMPS (Fig. 5A ).
KT5823 also blocked the effect of dibutyryl-cGMP on mitochondrial membrane potential (Fig. 5B) , cytochrome c release (Fig. 5C ) and caspase-3-like protease activation (Fig. 5D) .
A pilot experiment showed that exposure of purified rat brain mitochondria to 30-100 µM Ca 2+ caused a significant decrease in absorbance, indicating mitochondrial swelling by the PTP opening (data not shown). The swelling was dependent on Ca 2+ concentration as reported previously (26) . In this study, we used 100 µM Ca 2+ to induce mitochondrial swelling. The swelling was inhibited by the mitochondrial PTP inhibitors cyclosporin A (28) and bongkrekic acid (29) (Fig. 6A) . Neither cGMP nor cytosolic extract from astrocytes affected the Ca 2+ -induced mitochondrial swelling, but simultaneous addition of cGMP and the cytosolic extract prevented the swelling in dose-dependent manners (Fig. 6B, 6C ). The effect of cGMP plus the cytosolic extract was also observed in the swelling induced by 30 µM Ca 2+ (data not shown). The ability of the cytosolic extract was inactivated by heat-treating it (Fig.  7A) and was mimicked by exogenous PKG (Fig. 7B) . The similar protection by cGMP against Ca 2+ -induced swelling was observed even when cGMP was added together with or after Ca 2+ (data not shown). KT5823 antagonized the effect of cGMP plus the cytosolic extract (Fig. 7C) or PKG (Fig. 7B ) in inhibiting the Ca 2+ -induced swelling. The mitochondrial PTP inhibitors cyclosporin A and bongkrekic acid inhibited the H 2 O 2 -induced decrease in MTT reduction activity and activation of caspase-3-like protease in cultured astrocytes (Fig. 8) . In this experiment, bongkrekic acid was used at a relatively low concentration, because at 50 µM it showed cell toxicity (data not shown).
DISCUSSION
This study was undertaken to characterize the mechanism by which cGMP suppresses the H 2 O 2 -induced apoptosis in cultured astrocytes. The membrane-permeable cGMP analogs dibutyryl-cGMP, 8-pCPT-cGMP and Sp-8-pCPT-cGMPS attenuated the H 2 O 2 -induced decrease in cell viability. In view of the importance of mitochondria in the apoptotic process, the present study focused on the effect of cGMP on the H 2 O 2 -induced mitochondrial dysfunction. We showed that dibutyryl-cGMP prevented the reduction of the mitochondrial membrane potential and cytochrome c release, and consequently abolished caspase-3 activation, nuclear condensation and DNA fragmentation in cultured astrocytes. These findings suggest that cGMP inhibits the H 2 O 2 -induced mitochondrial dysfunction and prevents astrocyte apoptosis. The inhibitory effect of cGMP analog on caspase-3 activation and cytochrome c release was also observed in hepatocytes (17, 18) and PC12 cells (19) . Many of the cellular effects of cGMP are mediated by PKG. In this respect, Kim et al. (19) reported that the PKG inhibitor KT5823 reversed 8-Br-cGMP-mediated prevention of cytochrome c release and caspase-3 activation in PC12 cells. We also found that KT5823 almost completely blocked the protection provided by dibutyryl-cGMP against the H 2 O 2 -induced reduction of the mitochondrial membrane potential, cytochrome c release and caspse-3 activation in astrocytes. These findings suggest that cGMP analogs prevent astrocyte apoptosis via the activation of PKG, although the exact mechanism by which cGMP/PKG prevents apoptotic events is not known.
Li et al. (18) reported that cAMP as well as cGMP analogs suppressed tumor necrosisfactor α plus actinomycin D-induced apoptosis in hepatocytes. However, it is unlikely that cAMP signaling also plays a role in prevention of astrocyte apoptosis, since cAMP phosphodiesterase inhibitors does not protect astrocytes against the H 2 O 2 -induced cytotoxicity (11) . On the other hand, we reported that the extracellular signal-regulated kinase (ERK) signal plays a role in the protective effect of T-588 and NGF against H 2 O 2 -induced astrocyte apoptosis (9) . In view of the recent studies that cGMP activates ERK (30) (31) (32) , it was considered whether the effect of cGMP reported here may be mediated by the activation of by guest on January 8, 2018
http://www.jbc.org/ Downloaded from ERK or phosphatidylinositol-3 kinase. However, the protective effect of dibutyryl-cGMP was observed even in the presence of the ERK kinase inhibitor PD98059 and the phosphoinositide-3 kinase inhibitor wortmannin.
Activation of the mitochondrial PTP has been identified as a possible common effector of the cell death of numerous cell types in response to both necrotic and apoptotic stimuli (33, 34) . Thus, it seems likely that the anti-apoptotic effect of cGMP may be mediated by inhibition of the mitochondrial PTP, however there are no reports on the effect of cGMP on the PTP. We demonstrate here that cGMP together with PKG, as well as cyclosporin A and bongkrekic acid, inhibits the Ca 2+ -induced mitochondrial swelling in isolated brain mitochondria. The effect of cGMP is dose-dependent and observed even at 1 μM, suggesting that cGMP is an endogenous potent inhibitor of the PTP. The effect of cGMP on the mitochondrial PTP required the presence of the cytosolic extract and the ability of the cytosolic extract was inactivated by heat-treatment. Furthermore, the effect of cGMP plus the cytosolic extract was antagonized by KT5823, and exogenous PKG mimicked the effect of the cytosolic extract. Taken together, it is likely that cGMP inhibits the mitochondrial PTP via the activation of PKG.
The mitochondrial PTP is formed from a complex of the voltage-dependent anion channel, the adenine nucleotide translocase and cyclophilin-D at contact sites between the mitochondrial outer and inner membranes. It is regulated by numerous endogenous physiological effectors such as ions, protons, the mitochondrial transmembrane potential, the concentration of adenine nucleotides, the pyrimidine redox state, the thiol redox state, reactive oxygen species and Bcl-2 family proteins (34). Genaro et al. (12) reported that an induction of Bcl-2 is involved in the anti-apoptotic effect of cGMP in splenocytes. In contrast, the effect of cGMP was observed even when it was added together with or after Ca 2+ . In view of the rapid effect of cGMP, it is unlikely that these endogenous effectors may be involved in the effect of cGMP on the mitochondrial PTP. The present study using a cell-free system suggests that cGMP interacts directly with mitochondria resulting in inhibition of the mitochondrial PTP via the activation of PKG. It is not known how cGMP/PKG signaling affects the mitochondrial PTP. Known substrates for PKG include inositol 1,4,5-trisphosphate receptor (35) , DARPP-32 (36) , and cGMP-binding phosphodiesterase (37) in the central nervous system. Schlossmann et al. (38) have recently identified a PKG substrate protein in smooth muscle. However, the role of these substrates in the inhibition by cGMP of the mitochondrial PTP is not clear.
There are a limited number of inhibitors of the mitochondrial PTP. The most specific inhibitor is cyclosporin A, which competitively prevents cyclophilin from interacting with specific cyclophilin-dependent binding domains of the pore. Other classes of inhibitors of the mitochondrial PTP consist of the adenine nucleotide translocase ligand bongkrekic acid (29) , the phospholipase inhibitor trifluoperazine (39), the antiestrogen drug tamoxifen (40) and nitric oxide (41) . Consistent with recent studies in other cells (42) (43) (44) , we found that the PTP inhibitors cyclosporin A and bongkrekic acid prevented the H 2 O 2 -induced reduction in cell viability and caspase-3 activation in astrocytes. In view of the evidence implicating the mitochondrial PTP in ischemia-related tissue damage, it has become important to identify strategies to inhibit induction of the PTP opening. The present study demonstrates that cGMP inhibits the mitochondrial PTP opening resulting in apoptotic events via the activation of PKG. This suggests that cGMP/PKG signaling is a novel target for prevention of mitochondrial dysfunction-mediated cell death. In line with this, we have shown that cGMP phosphodiesterase inhibitors including ibudilast protect astrocytes against reperfusion injury via cGMP/PKG signaling (11) . 
